If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article ...
Concerns over misuse, side effects and counterfeits are tightening controls on the blockbuster treatments, says Iona ...
A game-changer for UPC tech disputes ...
Former Latham & Watkins global vice chair joins the firm as co-chair of its technology transactions practice | New partner ...
Delaware federal judge reverses jury verdict in CareDx’s favour | Natera’s patents covering organ transplant testing ...
The company’s nine-country ban against a Chinese rival saw the court adopt a broad interpretation of means-plus-function ...
In Wuhan Healthgen Biotech v ITC, the Federal Circuit affirmed the US International Trade Commission’s (ITC) conclusion that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results